These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32000189)

  • 21. Cannabinoid Hyperemesis Syndrome and the Consulting Psychiatrist: A Case Study of Diagnosis and Treatment for an Emerging Disorder in Psychiatric Practice.
    Kast KA; Gershengoren L
    J Psychiatr Pract; 2018 Jan; 24(1):51-55. PubMed ID: 29320384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabinoid hyperemesis syndrome: a review of the literature.
    Deceuninck E; Jacques D
    Psychiatr Danub; 2019 Sep; 31(Suppl 3):390-394. PubMed ID: 31488758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of topical capsaicin for the treatment of cannabinoid hyperemesis syndrome: A retrospective cohort study.
    Yusuf HM; Geier C; Staidle A; Montoy JCC
    Am J Emerg Med; 2021 May; 43():142-148. PubMed ID: 33561623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoid hyperemesis syndrome in two French emergency departments: a prospective cohort.
    Weiss J; Torrents R; Verhamme B; Roch A; Lazerges P; Jego M; Michelet P; Simon N
    Fundam Clin Pharmacol; 2021 Feb; 35(1):186-191. PubMed ID: 32564375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoid hyperemesis syndrome: A case study and discussion.
    Creedon ES; Maloy MK; DelloStritto RA
    J Am Assoc Nurse Pract; 2020 Mar; 32(3):269-276. PubMed ID: 31274681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm.
    Wallace EA; Andrews SE; Garmany CL; Jelley MJ
    South Med J; 2011 Sep; 104(9):659-64. PubMed ID: 21886087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Capsaicin Cream in Cannabinoid Hyperemesis Syndrome in Patients Presenting to the Emergency Department.
    Lee A; Coralic Z
    Ann Pharmacother; 2022 Feb; 56(2):151-154. PubMed ID: 33998315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haloperidol, a Novel Treatment for Cannabinoid Hyperemesis Syndrome.
    Witsil JC; Mycyk MB
    Am J Ther; 2017; 24(1):e64-e67. PubMed ID: 25393073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid Hyperemesis Syndrome in a 17-Year-Old Adolescent.
    Desjardins N; Jamoulle O; Taddeo D; Stheneur C
    J Adolesc Health; 2015 Nov; 57(5):565-7. PubMed ID: 26372366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases.
    Nourbakhsh M; Miller A; Gofton J; Jones G; Adeagbo B
    J Forensic Sci; 2019 Jan; 64(1):270-274. PubMed ID: 29768651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and Acute Management of Adolescent Cannabinoid Hyperemesis Syndrome: A Systematic Review.
    Zhu JW; Gonsalves CL; Issenman RM; Kam AJ
    J Adolesc Health; 2021 Feb; 68(2):246-254. PubMed ID: 33036874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoid Hyperemesis Syndrome in an Athlete.
    Fleshman B; Kaiser K
    J Am Board Fam Med; 2021; 34(4):811-813. PubMed ID: 34312273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suicide attempt in the setting of cannabinoid hyperemesis syndrome: A case report.
    Moore E; Manoharan SVRR; McMillan L; Hussain N
    Ann Clin Psychiatry; 2019 Aug; 31(3):224-225. PubMed ID: 31369661
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnosing and treating cannabinoid hyperemesis.
    Wilson O; Lutton S; Doherty K
    Emerg Nurse; 2015 Dec; 23(8):22-5. PubMed ID: 26638755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Cannabinoid Hyperemesis Syndrome: Focus on Capsaicin.
    Stumpf JL; Williams LD
    J Pharm Pract; 2021 Oct; 34(5):786-793. PubMed ID: 32613883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of topical capsaicin for cannabinoid hyperemesis syndrome in a pediatric and adult emergency department.
    Kum V; Bell A; Fang W; VanWert E
    Am J Emerg Med; 2021 Nov; 49():343-351. PubMed ID: 34242945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical capsaicin for the treatment of cannabinoid hyperemesis syndrome, a systematic review and meta-analysis.
    Pourmand A; Esmailian G; Mazer-Amirshahi M; Lee-Park O; Tran QK
    Am J Emerg Med; 2021 May; 43():35-40. PubMed ID: 33493995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoid hyperemesis syndrome: definition, pathophysiology, clinical spectrum, insights into acute and long-term management.
    Gajendran M; Sifuentes J; Bashashati M; McCallum R
    J Investig Med; 2020 Dec; 68(8):1309-1316. PubMed ID: 33115959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cannabinoid hyperemesis syndrome: about 6 cases].
    Bertolino J; Abdo L; Khau D; Meckenstock R; Sautereau N; Jean E; Greder-Belan A; Frances Y; Cabane J; Granel B
    Rev Med Interne; 2015 Oct; 36(10):694-7. PubMed ID: 25547957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabinoid hyperemesis syndrome. A report of six new cases and a summary of previous reports.
    Contreras Narváez C; Mola Gilbert M; Batlle de Santiago E; Bigas Farreres J; Giné Serven E; Cañete Crespillo J
    Adicciones; 2016 Mar; 28(2):90-8. PubMed ID: 26990261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.